Emes2 Pharmaceuticals, LLC
Clearwater, FL Doing business as RX Return Services
- UEI
- L9BAWRKDMLD4
- CAGE
- 7UN82
- Primary NAICS
- 456110 Pharmacies and Drug Retailers
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1115 Old Coachman Rd., Clearwater, FL 33765, USA
- Website
- rxrs.com
- Founded
- 2012
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 51 Wholesale Trade – Nondurable Goods
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Reverse distribution services for expired pharmaceuticals, albuquerque service unit | Assistant Secretary for Financial Resources | $31,500 | |
| Disposal of expired/damaged controlled substances | Federal Correctional Institution Otisville | $6,860 | |
| FY26 B1 RX return MED returns AUG 26 | United States Penitentiary Marion | $0 | |
| FY26 RX return service reverse dist annual | Federal Correctional Institution Terminal Island | $3,300 | |
| FY26 B1 RX return MED returns FEB 26 | United States Penitentiary Marion | $4,150 |
About Emes2 Pharmaceuticals, LLC
Emes2 Pharmaceuticals, LLC, doing business as RX Return Services, is a self-certified small disadvantaged business based in Clearwater, Florida that provides pharmaceutical reverse distribution, waste management, and controlled-substance disposal services to federal healthcare and correctional facilities as a prime contractor on full-and-open purchase orders and indefinite delivery contracts. The company operates as a limited liability partnership structured for profit and competes without set-aside designation on most awards, though it qualifies for and has won several total small business set-asides with the Indian Health Service and Department of Veterans Affairs.
Emes2 Pharmaceuticals' capability portfolio centers on the removal, management, and destruction of expired, unused, and controlled medications from federal pharmacy operations. Representative work includes a $156.6 thousand purchase order with the Indian Health Service for quarterly reverse distributor services at the Santa Fe Indian Health Service facility (set aside for small business under the Buy Indian program, running through June 2027); a $67.6 thousand contract with IHS for pharmaceutical disposal at the Zuni Service Unit in New Mexico (total small business set-aside, ultimate completion June 2027); a $60.17 thousand delivery order with Department of Veterans Affairs Veterans Integrated Service Network 16 for expired pharmaceutical removal across VA facilities in Louisiana including Overton Brooks VA Medical Center (January 2024 through January 2029); and a $55 thousand single-award IDC with VISN 16 for reverse distribution of expired and DEA-controlled substances from VA facilities, with an ultimate completion date of January 2029. The company also holds recurring annual purchase orders from Federal Correctional Institution Terminal Island, Federal Correctional Institution Fort Worth, and United States Penitentiary Marion for on-site medication removal and destruction.
Customer concentration is pronounced. The Indian Health Service accounts for 8 awards worth $350 thousand combined potential value (60% of the portfolio), followed by the Department of Veterans Affairs Veterans Integrated Service Network 16 with 5 awards worth $192 thousand (33% of portfolio). The Federal Bureau of Prisons across three facilities (Terminal Island, Fort Worth, Marion) rounds out the active customer set with 7 awards totaling $38 thousand. These five customer entities cover 100% of recent awards. Emes2 Pharmaceuticals holds a single parent vehicle — an indefinite delivery contract (36C25624D0030) with VISN 16 that carries 2 task orders worth $71 thousand in combined potential value.
Activity has been episodic. The company averaged one award per year from 2022 through 2025, with a spike to six awards in 2024 and three awards year-to-date in 2026. Five awards worth $294 thousand combined potential value face ultimate completion within the next twenty-four months, representing significant recompete exposure. The company operates entirely as a prime — zero subcontract work appears in the source data. Combined potential value across the portfolio stands at $581 thousand, with $374 thousand (64% of the total) already obligated.
Quick answers
What is Emes2 Pharmaceuticals, LLC's UEI?
Emes2 Pharmaceuticals, LLC's Unique Entity ID (UEI) in SAM.gov is L9BAWRKDMLD4.
What is Emes2 Pharmaceuticals, LLC's CAGE code?
Emes2 Pharmaceuticals, LLC's CAGE code is 7UN82.
What is Emes2 Pharmaceuticals, LLC's primary NAICS code?
Emes2 Pharmaceuticals, LLC's primary NAICS code is 456110 (Pharmacies and Drug Retailers).
Where is Emes2 Pharmaceuticals, LLC located?
Emes2 Pharmaceuticals, LLC's physical address in SAM.gov is 1115 Old Coachman Rd., Clearwater, FL 33765, USA.
Is Emes2 Pharmaceuticals, LLC registered in SAM.gov?
Yes. Emes2 Pharmaceuticals, LLC's SAM.gov registration is active through September 17, 2027.
What is Emes2 Pharmaceuticals, LLC's most recent federal award?
Emes2 Pharmaceuticals, LLC's most recent federal contract award is Reverse distribution services for expired pharmaceuticals, albuquerque service unit (7571PS26P00038), from Assistant Secretary for Financial Resources, on September 15, 2026.
On GovTribe
See Emes2 Pharmaceuticals, LLC's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors